Created in 2004 (United States), CORUS PHARMA own 32 sister brands and 17477 competing brands. The CORUS PHARMA brand is owned by Gilead Sciences, a company listed in New York. CORUS PHARMA is part of the Drug Manufacturers activity sector.

CORUS PHARMA is a brand of Gilead Sciences (GILD) Share price

International deposit : 2004 Business sector Drug Manufacturers

Share price and profitability of the share Gilead Sciences (CORUS PHARMA)

Buy Gilead Sciences share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 67.75

Portfolio valuation
Gilead Sciences (CORUS PHARMA) over 5 years* USD 72.68

Stock market history Gilead Sciences (CORUS PHARMA)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Gilead Sciences

EpiTherapeutics
EpiTherapeutics
Nimbus Apollo
Nimbus Apollo
Cell Design Labs
Cell Design Labs
Forty Seven
Forty Seven
GILEAD SCIENCES
GILEAD SCIENCES
Kite Pharma
Kite Pharma
See more brands of Gilead Sciences

Rival brands
CORUS PHARMA

POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS